Handel Ocugen, Inc. - OCGN CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Handelsbetingelser
| Spænd | 0.05 | ||||||||
|
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.025457% | ||||||||
|
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.003235% | ||||||||
| Gebyr natten over, tid | 21:00 (UTC) | ||||||||
| Min. handlet mængde | 1 | ||||||||
| Valuta | USD | ||||||||
| Margen | 20% | ||||||||
| Aktiebørs | United States of America | ||||||||
| Kommission på handel | 0% |
*Information provided by Capital.com
Ocugen Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Nøglestatistikker
| Tidligere luk* | 0.45 |
| Åben* | 0.44 |
| 1-Års Ændring* | -81.03% |
| Dagens Spænd* | 0.44 - 0.44 |
| 52-Ugers Spænd | 0.44-3.11 |
| Gennemsnitlig Volumen (10 dage) | 12.97M |
| Gennemsnitlig Volumen (3 måneder) | 156.66M |
| Market Cap | 123.26M |
| P/E-forhold | -100.00K |
| Udestående aktier | 260.93M |
| Omsætning | N/A |
| EPS | -0.36 |
| Dividend (Udbytte %) | N/A |
| Beta | 3.88 |
| Næste indtjeningsopgørelse | Aug 3, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Luk | Change | Change (%) | Åben | High | Low |
|---|---|---|---|---|---|---|
| Jun 5, 2023 | 0.45 | 0.00 | 0.00% | 0.45 | 0.46 | 0.45 |
| Jun 2, 2023 | 0.43 | 0.00 | 0.00% | 0.43 | 0.43 | 0.43 |
| Jun 1, 2023 | 0.43 | 0.00 | 0.00% | 0.43 | 0.43 | 0.43 |
| May 31, 2023 | 0.43 | 0.00 | 0.00% | 0.43 | 0.44 | 0.43 |
| May 30, 2023 | 0.43 | -0.02 | -4.44% | 0.45 | 0.45 | 0.43 |
| May 26, 2023 | 0.44 | 0.01 | 2.33% | 0.43 | 0.44 | 0.42 |
| May 25, 2023 | 0.43 | -0.04 | -8.51% | 0.47 | 0.47 | 0.43 |
| May 24, 2023 | 0.45 | -0.08 | -15.09% | 0.53 | 0.53 | 0.43 |
| May 23, 2023 | 0.69 | -0.01 | -1.43% | 0.70 | 0.75 | 0.69 |
| May 22, 2023 | 0.69 | 0.05 | 7.81% | 0.64 | 0.71 | 0.63 |
| May 19, 2023 | 0.65 | 0.01 | 1.56% | 0.64 | 0.65 | 0.63 |
| May 18, 2023 | 0.63 | -0.04 | -5.97% | 0.67 | 0.67 | 0.61 |
| May 17, 2023 | 0.67 | 0.00 | 0.00% | 0.67 | 0.67 | 0.65 |
| May 16, 2023 | 0.67 | -0.01 | -1.47% | 0.68 | 0.71 | 0.66 |
| May 15, 2023 | 0.71 | 0.06 | 9.23% | 0.65 | 0.72 | 0.65 |
| May 12, 2023 | 0.65 | -0.04 | -5.80% | 0.69 | 0.69 | 0.64 |
| May 11, 2023 | 0.68 | -0.05 | -6.85% | 0.73 | 0.73 | 0.67 |
| May 10, 2023 | 0.72 | 0.01 | 1.41% | 0.71 | 0.74 | 0.70 |
| May 9, 2023 | 0.70 | 0.00 | 0.00% | 0.70 | 0.71 | 0.67 |
| May 8, 2023 | 0.70 | 0.00 | 0.00% | 0.70 | 0.72 | 0.68 |
Ocugen, Inc. Events
| Tid (UTC) (UTC) | Land | Begivenhed |
|---|---|---|
| Wednesday, June 7, 2023 | ||
| Tid (UTC) (UTC) 12:00 | Land US
| Begivenhed Ocugen Inc Annual Shareholders Meeting Ocugen Inc Annual Shareholders MeetingForecast -Previous - |
| Friday, June 9, 2023 | ||
| Tid (UTC) (UTC) 12:00 | Land US
| Begivenhed Ocugen Inc Annual Shareholders Meeting Ocugen Inc Annual Shareholders MeetingForecast -Previous - |
| Thursday, August 3, 2023 | ||
| Tid (UTC) (UTC) 12:30 | Land US
| Begivenhed Q2 2023 Ocugen Inc Earnings Release Q2 2023 Ocugen Inc Earnings ReleaseForecast -Previous - |
| Monday, November 6, 2023 | ||
| Tid (UTC) (UTC) 13:30 | Land US
| Begivenhed Q3 2023 Ocugen Inc Earnings Release Q3 2023 Ocugen Inc Earnings ReleaseForecast -Previous - |
- Årlig
- Pr kvartal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total omsætning | 0 | 0 | 0.04262 | 0 | 0 |
| Omsætning | 0 | 0.04262 | 0 | ||
| Totale Driftsudgifter | 84.868 | 57.628 | 21.3273 | 14.5038 | 28.568 |
| Salgs/Generelle/Admin. Udgifter, Total | 35.111 | 22.92 | 7.97405 | 6.0771 | 10.204 |
| Forskning & Udvikling | 49.757 | 35.108 | 13.3533 | 8.08552 | 15.634 |
| Usædvanlig Udgift (Indkomst) | -0.4 | 0 | 0.34114 | 2.73 | |
| Driftsindtægter | -84.868 | -57.628 | -21.2847 | -14.5038 | -28.568 |
| Renteindkomst (Udgift), Netto Ikke-Drift | -0.079 | -0.71989 | -4.95401 | 20.031 | |
| Andre, Netto | 3.517 | -0.71 | 0.18266 | -0.78487 | -0.106 |
| Netto Indkomst Før Skat | -81.351 | -58.417 | -21.822 | -20.2426 | -8.643 |
| Netto Indkomst Efter Skat | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
| Netto Indkomst Før Ekstra Ting | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
| Netto Indkomst | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
| Total Adjustments to Net Income | 0 | -12.5463 | 0.121 | ||
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -81.351 | -58.365 | -34.3683 | -20.2426 | -8.522 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -81.351 | -58.365 | -34.3683 | -20.2426 | -8.522 |
| Fortyndet Netto Indkomst | -81.351 | -58.365 | -34.3683 | -20.2426 | -8.522 |
| Fortyndet Vægtet Gennemsnit Aktier | 214.6 | 195.013 | 112.236 | 13.8938 | 0.60676 |
| Fortyndet EPS Uden Ekstraordinære Ting | -0.37908 | -0.29929 | -0.30621 | -1.45695 | -14.045 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Fortyndet Normaliseret EPS | -0.37908 | -0.30062 | -0.30621 | -1.4324 | -9.54575 |
| Totale Ekstraordinære Ting | 0 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total omsætning | 0 | 0 | 0 | 0 | 0 |
| Totale Driftsudgifter | 17.751 | 24.15 | 23.119 | 19.565 | 18.034 |
| Salgs/Generelle/Admin. Udgifter, Total | 8.193 | 6.937 | 7.497 | 10.558 | 10.119 |
| Forskning & Udvikling | 9.558 | 17.213 | 15.622 | 9.007 | 7.915 |
| Driftsindtægter | -17.751 | -24.15 | -23.119 | -19.565 | -18.034 |
| Renteindkomst (Udgift), Netto Ikke-Drift | |||||
| Netto Indkomst Før Skat | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
| Netto Indkomst Efter Skat | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
| Netto Indkomst Før Ekstra Ting | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
| Netto Indkomst | -16.498 | -21.939 | -21.922 | -19.471 | -18.019 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -16.499 | -21.939 | -21.922 | -19.471 | -18.019 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -16.499 | -21.939 | -21.922 | -19.471 | -18.019 |
| Fortyndet Netto Indkomst | -16.499 | -21.939 | -21.922 | -19.471 | -18.019 |
| Fortyndet Vægtet Gennemsnit Aktier | 225.524 | 220.133 | 216.591 | 215.863 | 205.693 |
| Fortyndet EPS Uden Ekstraordinære Ting | -0.07316 | -0.09966 | -0.10121 | -0.0902 | -0.0876 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Fortyndet Normaliseret EPS | -0.07316 | -0.09966 | -0.10121 | -0.0902 | -0.0876 |
| Omsætning | |||||
| Andre, Netto | 1.253 | 2.211 | 1.197 | 0.094 | 0.015 |
| Total Adjustments to Net Income | -0.001 | ||||
| Usædvanlig Udgift (Indkomst) |
- Årlig
- Pr kvartal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 98.492 | 102.646 | 25.8777 | 15.7662 | 16.4 |
| Likvider og Kortsigtede Investeringer | 90.934 | 94.958 | 24.0393 | 7.44405 | 15.542 |
| Likvider & Lignende | 77.563 | 94.958 | 24.0393 | 7.44405 | 15.542 |
| Prepaid Expenses | 7.558 | 2.7 | 1.83836 | 1.32217 | 0.686 |
| Total Assets | 108.632 | 105.761 | 27.3764 | 16.8074 | 17.428 |
| Property/Plant/Equipment, Total - Net | 9.963 | 2.751 | 1.06662 | 0.22246 | 0.141 |
| Intangibles, Net | |||||
| Other Long Term Assets, Total | 0.177 | 0.364 | 0.43205 | 0.81876 | 0.887 |
| Total Current Liabilities | 18.46 | 7 | 3.61355 | 4.54396 | 2.873 |
| Accounts Payable | 8.062 | 2.312 | 0.39503 | 1.89561 | 1.59 |
| Accrued Expenses | 10.398 | 4.688 | 2.97464 | 2.44236 | 1 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 0.23412 | 0 | 0 | |
| Other Current Liabilities, Total | 0.00976 | 0.20599 | 0.283 | ||
| Total Liabilities | 24.58 | 9.943 | 5.82591 | 5.78904 | 17.886 |
| Total Long Term Debt | 2.289 | 1.712 | 1.82304 | 1.07212 | 0 |
| Long Term Debt | 2.289 | 1.712 | 1.82304 | 1.07212 | |
| Other Liabilities, Total | 3.831 | 1.231 | 0.38932 | 0.17295 | 15.013 |
| Total Equity | 84.052 | 95.818 | 21.5504 | 11.0184 | -0.458 |
| Common Stock | 2.217 | 1.995 | 1.84133 | 0.52747 | 0.513 |
| Additional Paid-In Capital | 294.874 | 225.537 | 93.0587 | 62.0186 | 215.859 |
| Retained Earnings (Accumulated Deficit) | -213.018 | -131.667 | -73.3018 | -51.4798 | -216.83 |
| Total Liabilities & Shareholders’ Equity | 108.632 | 105.761 | 27.3764 | 16.8074 | 17.428 |
| Total Common Shares Outstanding | 221.6 | 199.381 | 184.012 | 52.6252 | 1.03376 |
| Kortsigtede Investeringer | 13.371 | 0 | |||
| Redeemable Preferred Stock | 0.001 | 0.001 | 0 | 0 | |
| Other Equity, Total | 0.026 | 0 | |||
| Other Current Assets, Total | 4.988 | 0 | 7 | 0.172 | |
| Property/Plant/Equipment, Total - Gross | 10.584 | 3.125 | 1.29231 | 10.427 | |
| Accumulated Depreciation, Total | -0.621 | -0.374 | -0.2257 | -10.286 | |
| Treasury Stock - Common | -0.048 | -0.048 | -0.04786 | -0.04786 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 84.401 | 98.492 | 107.497 | 122.569 | 138.027 |
| Likvider og Kortsigtede Investeringer | 76.721 | 90.934 | 101.602 | 115.005 | 129.771 |
| Likvider & Lignende | 68.259 | 77.563 | 101.602 | 115.005 | 129.771 |
| Prepaid Expenses | 7.68 | 7.558 | 5.895 | 7.564 | 8.256 |
| Other Current Assets, Total | |||||
| Total Assets | 96.299 | 108.632 | 116.239 | 130.088 | 141.727 |
| Property/Plant/Equipment, Total - Net | 7.952 | 9.963 | 8.557 | 7.325 | 3.345 |
| Property/Plant/Equipment, Total - Gross | 8.739 | 10.584 | 9.135 | 7.847 | 3.786 |
| Accumulated Depreciation, Total | -0.787 | -0.621 | -0.578 | -0.522 | -0.441 |
| Other Long Term Assets, Total | 3.946 | 0.177 | 0.185 | 0.194 | 0.355 |
| Total Current Liabilities | 15.683 | 18.46 | 14.907 | 10.338 | 7.687 |
| Accounts Payable | 8.092 | 8.062 | 6.46 | 5.921 | 3.896 |
| Accrued Expenses | 6.335 | 10.398 | 8.447 | 4.417 | 3.791 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 1.256 | ||||
| Total Liabilities | 20.499 | 24.58 | 20.936 | 15.98 | 10.598 |
| Total Long Term Debt | 1.058 | 2.289 | 2.265 | 1.75 | 1.731 |
| Long Term Debt | 1.058 | 2.289 | 2.265 | 1.75 | 1.731 |
| Other Liabilities, Total | 3.758 | 3.831 | 3.764 | 3.892 | 1.18 |
| Total Equity | 75.8 | 84.052 | 95.303 | 114.108 | 131.129 |
| Common Stock | 2.265 | 2.217 | 2.168 | 2.163 | 2.158 |
| Additional Paid-In Capital | 303.073 | 294.874 | 284.231 | 281.139 | 278.704 |
| Retained Earnings (Accumulated Deficit) | -229.516 | -213.018 | -191.079 | -169.157 | -149.686 |
| Treasury Stock - Common | -0.048 | -0.048 | -0.048 | -0.048 | -0.048 |
| Other Equity, Total | 0.025 | 0.026 | 0.03 | 0.01 | |
| Total Liabilities & Shareholders’ Equity | 96.299 | 108.632 | 116.239 | 130.088 | 141.727 |
| Total Common Shares Outstanding | 226.427 | 221.6 | 216.688 | 216.15 | 215.631 |
| Redeemable Preferred Stock | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
| Kortsigtede Investeringer | 8.462 | 13.371 |
- Årlig
- Pr kvartal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Netto indkomst/Startlinje | -81.351 | -58.365 | -21.822 | -20.2426 | -8.643 |
| Likvider Fra Driftsaktiviteter | -60.079 | -47.941 | -14.7087 | -16.8933 | -15.777 |
| Likvider Fra Driftsaktiviteter | 0.48 | 0.229 | 0.10211 | 0.06061 | 0.45 |
| Ikke-Likvide Ting | 11.597 | 7.757 | 8.2213 | 6.40129 | -14.779 |
| Cash Taxes Paid | 0 | 0.052 | 0.105 | ||
| Likvid Rente Betalt | 0.001 | ||||
| Ændringer i Driftskapital | 9.195 | 2.438 | -1.21018 | -3.11255 | 7.195 |
| Likvider fra Investeringsaktiviteter | -16.967 | -1.816 | -0.30683 | -2.35672 | -1.113 |
| Kapitaludgifter | -4.457 | -1.066 | -0.30683 | -0.02945 | -2.013 |
| Likvider fra Financieringsaktiviteter | 59.475 | 120.676 | 31.611 | 25.0665 | 25.351 |
| Financiering af Cash-Flow-Ting | -0.592 | -8.525 | -1.48355 | -0.17293 | -0.178 |
| Udstedelse (Pensionering) af Aktier, Netto | 59.567 | 129.211 | 37.822 | 23.7294 | 25.529 |
| Netto Ændring i Likviditet | -17.546 | 70.919 | 16.5955 | 5.81646 | 8.461 |
| Andre Investerings-Cash-Flow-Ting, Total | -12.51 | -0.75 | 0 | -2.32727 | 0.9 |
| Udstedelse (Pensionering) af Gæld, Netto | 0.5 | -0.01 | -4.72744 | 1.51 | |
| Udenlandsk Børs Effekter | 0.025 | 0 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -16.498 | -81.351 | -59.412 | -37.49 | -18.019 |
| Cash From Operating Activities | -18.24 | -60.079 | -43.165 | -28.863 | -15.066 |
| Cash From Operating Activities | 0.174 | 0.48 | 0.307 | 0.166 | 0.076 |
| Non-Cash Items | 3.053 | 11.597 | 7.721 | 5.75 | 3.497 |
| Changes in Working Capital | -4.969 | 9.195 | 8.219 | 2.711 | -0.62 |
| Cash From Investing Activities | 3.441 | -16.967 | -1.672 | -1.589 | -0.223 |
| Capital Expenditures | -1.612 | -4.457 | -2.433 | -1.589 | -0.223 |
| Cash From Financing Activities | 5.496 | 59.475 | 51.3 | 50.338 | 50.102 |
| Financing Cash Flow Items | -0.235 | -0.592 | -0.398 | -0.248 | -0.075 |
| Issuance (Retirement) of Stock, Net | 5.731 | 59.567 | 51.198 | 50.586 | 50.177 |
| Issuance (Retirement) of Debt, Net | 0.5 | 0.5 | 0 | 0 | |
| Net Change in Cash | -9.304 | -17.546 | 6.493 | 19.896 | 34.813 |
| Other Investing Cash Flow Items, Total | 5.053 | -12.51 | 0.761 | 0 | |
| Cash Taxes Paid | 0 | 0 | |||
| Foreign Exchange Effects | -0.001 | 0.025 | 0.03 | 0.01 |
| Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
|---|---|---|---|---|---|---|
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.359 | 13983184 | 325773 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.9879 | 13014850 | 1186595 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.3269 | 6071506 | -42605 | 2023-04-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7864 | 4661333 | 517806 | 2023-03-31 | LOW |
| JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 1.1401 | 2974934 | -38269 | 2023-03-31 | LOW |
| Susquehanna International Group, LLP | Investment Advisor | 0.9278 | 2420929 | 1982473 | 2023-03-31 | HIGH |
| Renaissance Technologies LLC | Hedge Fund | 0.8744 | 2281548 | 858692 | 2023-03-31 | HIGH |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.6232 | 1626024 | -54370 | 2023-03-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 0.5821 | 1518828 | -101478 | 2023-03-31 | LOW |
| Ergoteles Capital | Hedge Fund | 0.5813 | 1516801 | 1516801 | 2023-03-31 | HIGH |
| Millennium Management LLC | Hedge Fund | 0.4858 | 1267682 | 1267682 | 2023-03-31 | HIGH |
| KVM Holdings, L.L.C. | Corporation | 0.4389 | 1145299 | 0 | 2023-04-13 | |
| HRT Financial LP | Investment Advisor | 0.3862 | 1007728 | 1007728 | 2023-03-31 | HIGH |
| Zhang (Junge) | Individual Investor | 0.3698 | 964904 | 0 | 2023-04-13 | |
| BNY Mellon Asset Management | Investment Advisor | 0.3315 | 865067 | 25820 | 2023-03-31 | LOW |
| Kompella (Uday B.) | Individual Investor | 0.2702 | 705090 | 0 | 2023-04-13 | |
| Nuveen LLC | Pension Fund | 0.2576 | 672249 | -483391 | 2023-03-31 | LOW |
| BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 0.23 | 600261 | 15607 | 2023-03-31 | LOW |
| Goldman Sachs & Company, Inc. | Research Firm | 0.1887 | 492420 | -900714 | 2023-03-31 | MED |
| BofA Global Research (US) | Research Firm | 0.1878 | 490023 | -2389134 | 2023-03-31 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group535K+
Handlende
87K+
Månedlkige, aktive klienter
$113M+
Månedlig investeringsvolumen
$64M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
Handelskurtage
0
- 1:1
Gearing
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben
Luk
Short Long
Ocugen, Inc. Company profile
Om Ocugen, Inc.
Ocugen, Inc. er en biofarmaceutisk virksomhed, der fokuserer på udvikling af genterapier til helbredelse af blindhedssygdomme og udvikling af vaccine mod COVID-19. Virksomhedens teknologipipipeline omfatter: COVID-19-vaccine (0,5), Modifier Gene Therapy Platform og nye biologiske terapier for nethindesygdomme. COVID-19-vaccinkandidaten er fokuseret på udvikling, fremstilling og markedsføring af COVAXIN til forebyggelse af COVID-19 hos mennesker i Ocugen Covaxin-territoriet. COVAXIN er en hel-virion inaktiveret COVID-19-vaccinkandidat og er formuleret med det inaktiverede SARS-CoV-2 virus. Modifier Gene Therapy-platformen er udviklet til nethindesygdomme, herunder retinitis pigmentosa (RP), leber congenital amaurosis (LCA) og tør aldersrelateret makuladegeneration (AMD). Virksomheden er ved at udvikle OCU200, en biologisk produktkandidat til behandling af diabetisk makulaødem (DME), diabetisk retinopati (DR) og våd AMD. OCU400, selskabets første produktkandidat, der udvikles med dets modificerende genterapiplatform.
| Industry: | Biotechnology & Medical Research (NEC) |
11 Great Valley Parkway
MALVERN
PENNSYLVANIA 19355
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 535.000+ handlende over hele verden, der valgte at handle hos Capital.com